-22.5% Avg body weight loss at highest dose (SURMOUNT-1) 96% Lost at least 5% body weight 72 weeks Trial duration Context: Clinical trial participants also received lifestyle intervention (diet and exercise counseling)
For patients experiencing significant discomfort, symptomatic management may be appropriate
It explains that an individual has PCOS if there is the presence of two out of three features: Oligo- or anovulation Oligoovulation is when ovulation occurs irregularly, leading to irregular or infrequent periods, while anovulation is when ovulation does not occur, leading to absent periods
If you want the mechanism, the evidence tier, and the honest regulatory status of the compounds that actually matter, subscribe
As central insulin resistance appears to be a risk factor for neurodegenerative disorders, these analogues might provide interesting avenues to protect against neurodegeneration and conditions such as Alzheimers and Parkinsons disease
DOI:10.1111/j.1473-2165.2005.40202.x [ Links ] 20